<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210209050307N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-03-13</date_registration>
      <primary_sponsor>Rafsanjan University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Head Cooling and Remote Conditioning in Traumatic Brain Injury</public_title>
      <acronym></acronym>
      <scientific_title>Effect of Head Cooling and Remote Conditioning in Limb on outcome of patients with Traumatic Brain Injury</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-04-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>84</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/54222</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients enter the groups randomly after visiting the emergency department. Patients who enter the hospital consecutively enter the study groups in order. Randomization is block type and people enter the hospital in the first, second, third or fourth block, respectively, Blinding description: After diagnosing the disease, the treating physician does not know the patient's entry into the desired group and the type of treatment, and also the patient has no information about the intervention and treatment.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Traumatic Brain Injury.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: There is no intervention on them. Intervention 2: Intervention group 2: Head cooling group: Hypothermia caps are usually made of synthetic materials such as neoprene, silicone or polyurethane and are cooled with a cooling agent such as ice and gel that can be cooled to -25 to -30 degrees Celsius before use. For repeated use of the caps, they are filled with krillon gel, which freezes up to -30 degrees Celsius. As the caps warm up during use, several ice caps are prepared, which must be replaced with a new, completely frozen ice cap every 20 to 30 minutes after use. In groups with ice caps, treatment is started immediately after admission. It is used for the first three consecutive days after admission for 0 to 6 hours (average 4.5 hours) depending on the patient's condition and tolerance to maintain the brain temperature at 33 to 34 degrees Celsius. The researcher measures the temperature of the brain with a tympanic membrane thermometer (the difference between the temperature of the tympanic membrane and the temperature of the brain is about 0.2 degrees Celsius). For this purpose, the brain temperature is likely to drop to about 33 to 34 degrees Celsius (it takes about 2 hours) and is maintained in the same range. Intervention 3: Intervention group 3: RIC Technique Group: Arm ischemia is a full 5-minute full blood pressure cuff and a 5-minute empty blood pressure cuff in which the cuff is filled to 200 mm Hg or the patient's systolic pressure plus 25 mm Hg. This will be done at the same time as putting on the ice cap in the golden hours after the injury. Intervention 4: Intervention group 4: Head cooling group and RIC technique.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is We are currently deciding to publish an article.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Amir moghadamahmadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Abozar 1/1</address>
        <city>Rafsanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7719794454</zip>
        <telephone>+98 34 3423 4191</telephone>
        <email>a.moghadamahmadi@gmail.com</email>
        <affiliation>Rafsanjan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>a.moghadamahmadi@gmail.com</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>abozar1/1</address>
        <city>Rafsanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7719794454</zip>
        <telephone>+98 34 3423 4191</telephone>
        <email>a.moghadamahmadi@gmail.com</email>
        <affiliation>Rafsanjan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Glawsco Coma Scale (GCS) score of less than 8</inclusion_criteria>
      <agemin>14 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>presence of known inflammatory disorder
history of neurological or psychological disorders
dependence to drugs or opium
mild Traumatic Brain Injury (TBI)
signs of disseminated injury without mass effect on brain Computed Tomography (CT) scan image</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Diagnosis</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: There is no intervention on them</i_keyword>
      <i_keyword>Intervention group 2: Head cooling group: Hypothermia caps are usually made of synthetic materials such as neoprene, silicone or polyurethane and are cooled with a cooling agent such as ice and gel that can be cooled to -25 to -30 degrees Celsius before use. For repeated use of the caps, they are filled with krillon gel, which freezes up to -30 degrees Celsius. As the caps warm up during use, several ice caps are prepared, which must be replaced with a new, completely frozen ice cap every 20 to 30 minutes after use. In groups with ice caps, treatment is started immediately after admission. It is used for the first three consecutive days after admission for 0 to 6 hours (average 4.5 hours) depending on the patient's condition and tolerance to maintain the brain temperature at 33 to 34 degrees Celsius. The researcher measures the temperature of the brain with a tympanic membrane thermometer (the difference between the temperature of the tympanic membrane and the temperature of the brain is about 0.2 degrees Celsius). For this purpose, the brain temperature is likely to drop to about 33 to 34 degrees Celsius (it takes about 2 hours) and is maintained in the same range.</i_keyword>
      <i_keyword>Intervention group 3: RIC Technique Group: Arm ischemia is a full 5-minute full blood pressure cuff and a 5-minute empty blood pressure cuff in which the cuff is filled to 200 mm Hg or the patient's systolic pressure plus 25 mm Hg. This will be done at the same time as putting on the ice cap in the golden hours after the injury</i_keyword>
      <i_keyword>Intervention group 4: Head cooling group and RIC technique</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>APACHE II scores. Timepoint: 72 hours -6 days- 2 months later. Method of measurement: questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Rafsanjan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-05-17</approval_date>
        <contact_name>Ethics committee of Rafsanjan University of Medical Sciences</contact_name>
        <contact_address>Emam Ali street Rafsanjan Kerman Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
